Zobrazeno 1 - 10
of 24
pro vyhledávání: '"George R, Gunn"'
Autor:
Karen Liao, Keguan Chen, Sara Brett, Andrew Gehman, Ann M Schwartz, George R Gunn, Stephen L DeWall
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0249049 (2021)
Interleukin-7 (IL-7) signaling modulates T cell activity and is implicated in numerous autoimmune diseases. An anti-IL-7 receptor monoclonal antibody (GSK2618960) biotherapeutic was evaluated in healthy subjects for safety, pharmacokinetics (PK), pha
Externí odkaz:
https://doaj.org/article/788236ade2a64347a34ce69e5cadabb4
Simple method to determine the concentration and incorporation ratio of ruthenium-labeled antibodies
Publikováno v:
Bioanalysis. 14:19-28
Aim: Ruthenium-labeled antibodies are commonly used detection reagents in bioanalysis assays and must be characterized to ensure quality. The aim of this work was to develop a method to determine the concentration and incorporation ratio (the degree
Autor:
Swati Gupta, Sylvie Bertholet, Daniela Verthelyi, Jason Delcarpini, George R Gunn, Richard Siggers, Anna Ma, Fabio Garofolo, Lisa Kierstead, Mark Milton, Francis Dessy, Johann Poetzl, Arno Kromminga, Boris Gorovits, Marco Petrillo, Madeleine Dahlbäck, Lynne Jesaitis, Robert J Kubiak, Becky Schweighardt, Mohsen Rajabi Abhari, Kay Stubenrauch, Meina Liang, Yanmei Lu, Susan Kirshner, Haoheng Yan, John Kamerud, Rocio Murphy, Naveen Dakappagari, Holger Koch, Akiko Ishii-Watabe, Yuanxin Xu, Sam Song, Michael A Partridge, Lucia Zhang, Chris Stebbins, Vibha Jawa, Andrew Exley, Elana Cherry, Jim McNally, Manoj Rajadhyaksha, Bart Corsaro, Bonnie Wu, Therese Solstad, Jean-Claude Marshall, Isabelle Cludts, Ivo Sonderegger, Sumit Kar, Tong-Yuan Yang, Roland F Staack, João Pedras-Vasconcelos, Natasha Savoie, Yuling Wu, Samuel O. Pine, Ghanashyam Sarikonda
Publikováno v:
Bioanalysis. 13:415-463
The 14th edition of the Workshop on Recent Issues in Bioanalysis (14th WRIB) was held virtually on June 15-29, 2020 with an attendance of over 1000 representatives from pharmaceutical/biopharmaceutical companies, biotechnology companies, contract res
Publikováno v:
Analytical Biochemistry. 664:115033
Degree of labeling and label efficiency are key factors for optimal characterization of critical reagents that are used in ligand binding assays. Here, three case studies are shown demonstrating how liquid chromatography-mass spectrometry (LC-MS) was
Autor:
Jim McNally, Szilárd Kamondi, Daniel Kramer, Honglue Shen, Vibha Jawa, Jane Ruppel, Charles S Hottenstein, Kelli R. Phillips, Meina Liang, Michael E Hodsdon, Dong Geng, Joanne Goodman, Mohsen Rajabi Ahbari, Heather Myler, Marta Starcevic Manning, Alvydas Mikulskis, William Hallett, Haoheng Yan, Adrienne Clements-Egan, Paul Chamberlain, Qiang Qu, ZhenZhen Liu, Carol Gleason, Viswanath Devanaryan, George R Gunn, Susan M. Richards, Theresa J Goletz, Troy E. Barger, Susana Liu, Lakshmi Amaravadi, Veerle Snoeck, Joao Pedras-Vasconcelos, Kathryn Lindley, Robert Nelson, Mark Ware, Shobha Purushothama, An Song, Susan Kirshner, Brian M Janelsins, Jad Zoghbi, Steven Bowen, Ronald R. Bowsher
Publikováno v:
The AAPS Journal. 24
Evolving immunogenicity assay performance expectations and a lack of harmonized anti-drug antibody validation testing and reporting tools have resulted in significant time spent by health authorities and sponsors on resolving filing queries. Followin
Autor:
Stephen DeWall, Sara Brett, Keguan Chen, Andrew Gehman, George R Gunn, Ann M. Schwartz, Karen Liao
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 3, p e0249049 (2021)
PLoS ONE, Vol 16, Iss 3, p e0249049 (2021)
Interleukin-7 (IL-7) signaling modulates T cell activity and is implicated in numerous autoimmune diseases. An anti-IL-7 receptor monoclonal antibody (GSK2618960) biotherapeutic was evaluated in healthy subjects for safety, pharmacokinetics (PK), pha
Autor:
Bart, Corsaro, Tong-Yuan, Yang, Rocio, Murphy, Ivo, Sonderegger, Andrew, Exley, Sylvie, Bertholet, Naveen, Dakappagari, Francis, Dessy, Fabio, Garofolo, Lisa, Kierstead, Holger, Koch, Ghanashyam, Sarikonda, Natasha, Savoie, Richard, Siggers, Therese, Solstad, Yanmei, Lu, Mark, Milton, Jean-Claude, Marshall, Jason, DelCarpini, Boris, Gorovits, Swati, Gupta, Lynne, Jesaitis, John, Kamerud, Arno, Kromminga, Anna, Ma, Jim, McNally, Haoheng, Yan, Bonnie, Wu, Daniela, Verthelyi, Susan, Kirshner, Joao, Pedras-Vasconcelos, Manoj, Rajadhyaksha, Roland F, Staack, Elana, Cherry, Isabelle, Cludts, Madeleine, Dahlbäck, George R, Gunn, Akiko, Ishii-Watabe, Vibha, Jawa, Robert, Kubiak, Michael, Partridge, Marco, Petrillo, Samuel O, Pine, Johann, Poetzl, Sam, Song, Chris, Stebbins, Yuling, Wu, Lucia, Zhang, Sumit, Kar, Meina, Liang, Mohsen Rajabi, Abhari, Becky, Schweighardt, Kay, Stubenrauch, Yuanxin, Xu
Publikováno v:
Bioanalysis. 13(6)
The 14
Autor:
Adrienne Clements-Egan, Binodh DeSilva, Viswanath Devanarayan, Boris Gorovits, George R. Gunn, Vinod P. Shah, Kelli R. Phillips, Susan Kirshner, Heather Myler
Publikováno v:
The AAPS Journal. 21
In September 2018, the American Association of Pharmaceutical Scientists (AAPS) conducted an Annual Guidance Forum on the considerations related to immunogenicity testing for therapeutic protein products. In addition to a broad representation by the
Autor:
David C.F. Sealey, Subrata Ghosh, Fakhreddin Jamali, Gopi Shankar, George R. Gunn, Bernd Meibohm
Publikováno v:
Clinical and Experimental Immunology. 184:137-146
Summary Unlike conventional chemical drugs where immunogenicity typically does not occur, the development of anti-drug antibodies following treatment with biologics has led to concerns about their impact on clinical safety and efficacy. Hence the elu
Autor:
George R Gunn, Zhenhua Xu, Omoniyi J. Adedokun, Cynthia Gargano, Jocelyn H. Leu, Paul Rutgeerts, William J. Sandborn, Gopi Shankar
Publikováno v:
Inflammatory bowel diseases. 25(9)
Background Antidrug antibody (ADA) detection with standard bridging enzyme immunoassays (EIA) can yield false-negative results or underestimate titers through drug interference. A more sensitive assay was needed to determine clinical impact of antigo